Clinical Trials in Phoenix

Showing 3841-3860 of 16,646 trials

JSI-1187-01 Monotherapy and in Combination With Dabrafenib for Advanced Solid Tumors With MAPK Pathway Mutations

NCT04418167

This is a Phase 1 study of JSI-1187 as monotherapy and in combination with dabrafenib for the treatment of advanced solid tumors with MAPK pathway mutations, including mutations that cause MAPK pathway hyperactivation.

Solid Tumors

JS InnoPharm, LLC71 participantsStarted Jun 2020

Phoenix, Arizona, United States • Tucson, Arizona, United States • San Francisco, California, United States +4 more locations

COMPLETEDPhase 2< 1 mile

Estetrol for the Treatment of Female Sexual Arousal Disorder in Postmenopausal Women

NCT06308614

The goal of this clinical trial is investigating estetrol (E4) in women after menopause, suffering from sexual arousal disorder. The main question it aims to answer is: is 20 mg estetrol monohydrate effective in the treatment of sexual arousal disorder in women after their menopause. Participants will visit the clinic 7 times and complete a daily diary while receiving estetrol or placebo for 12 weeks. Placebo is a pill that looks the same as estetrol but has no active ingredient. Researchers will compare estetrol and placebo to see if estetrol has an effect on the sexual arousal of the participants.

Sexual Dysfunction, Physiological

Estetra82 participantsStarted Jan 2024

Mesa, Arizona, United States • Phoenix, Arizona, United States • Tucson, Arizona, United States +21 more locations

JSI-1187-01 Monotherapy and in Combination With Dabrafenib for Advanced Solid Tumors With MAPK Pathway Mutations

Estetrol for the Treatment of Female Sexual Arousal Disorder in Postmenopausal Women

Find Trials by Condition in Phoenix

Long-Term Evaluation of BIIB067 (Tofersen)

A Study of LY3549492 in Adults With Obesity or Overweight With Type 2 Diabetes

A Study to Evaluate Biomarker Signature to Predict the Persistence of Post-traumatic Headache

Efficacy and Safety of KBP-5074 in Uncontrolled Hypertension and Moderate or Severe Chronic Kidney Disease (CKD)

Ferric Citrate for the Prevention of Renal Failure in Adults With Advanced Chronic Kidney Disease

A Study Investigating DNA-damage Response Agents in Molecularly Altered Advanced Cancer

HIV/STD Risk and PrEP Implementation Messaging Among Gay, Bisexual, and Other Men Who Have Sex With Men

The LATITUDE Study: Long-Acting Therapy to Improve Treatment SUccess in Daily LifE

Saroglitazar Magnesium 4 mg for Nonalcoholic Fatty Liver Disease (NAFLD) in People Living With HIV in the US

Post-approval Study of New Enrolment Patients Undergoing Bilateral Treatment With the VisuMax SMILE Procedure

Polatuzumab Vedotin, Rituximab, Ifosfamide, Carboplatin, and Etoposide (PolaR-ICE) as Initial Salvage Therapy for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma

A Study of Adjuvant Intismeran Autogene (V940) and Pembrolizumab in Renal Cell Carcinoma (V940-004).

INSPIRIS RESILIA Aortic Valve, Valve-in-Valve Surveillance Study

A Study of Abemaciclib in Recurrent Glioblastoma

A Study of the Safety, Tolerability, and Pharmacokinetics of Dolutegravir in Neonates Exposed to HIV-1

The Care Ecosystem Consortium Effectiveness Study

Tucatinib, Trastuzumab, and Capecitabine for the Treatment of HER2+ LMD

Effect of Evolocumab on Saphenous Vein Graft Patency Following Coronary Artery Bypass Surgery